Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study.
about
Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1NMR structural characterization of a minimal peptide antagonist bound to the extracellular domain of the corticotropin-releasing factor1 receptorStructure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligandNMR Structure of the First Extracellular Domain of Corticotropin-releasing Factor Receptor 1 (ECD1-CRF-R1) Complexed with a High Affinity AgonistGenetically encoded chemical probes in cells reveal the binding path of urocortin-I to CRF class B GPCRBrain stem catecholamines circuitry: activation by alcohol and role in the hypothalamic-pituitary-adrenal response to this drugCorticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.Oreochromis mossambicus (tilapia) corticotropin-releasing hormone: cDNA sequence and bioactivity.Neuropeptide Y acts within the rat testis to inhibit testosterone secretionChemical neuroimmunology: health in a nutshell bidirectional communication between immune and stress (limbic-hypothalamic-pituitary-adrenal) systems.Novel role of adrenergic neurons in the brain stem in mediating the hypothalamic-pituitary axis hyperactivity caused by prenatal alcohol exposureUrocortin 1 inhibits rat leydig cell function.Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state.Constitutive activation of tethered-peptide/corticotropin-releasing factor receptor chimeras.Corticotropin-releasing factor peptide antagonists: design, characterization and potential clinical relevanceAchieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.Peptide hormone evolution: functional heterogeneity within GnRH and CRF families.Interaction of an amphiphilic peptide with a phospholipid bilayer surface by molecular dynamics simulation study.An optimized solid phase synthesis strategy--including on-resin lactamization--of astressin, its retro-, inverso-, and retro-inverso isomers as corticotropin releasing factor antagonists.Comparison between the influence of the intravenous and intracerebroventricular injection of a nitric oxide donor on adrenocorticotropic hormone release and hypothalamic neuronal activity.Comparison between the influence of the systemic and central injection of alcohol on Leydig cell activity.Structure-activity studies on the corticotropin releasing factor antagonist astressin, leading to a minimal sequence necessary for antagonistic activity.Prenatal alcohol exposure blunts interleukin-1-induced ACTH and beta-endorphin secretion by immature rats.Effect of exposure to an alcohol diet for 10 days on the ability of interleukin-1 beta to release ACTH and corticosterone in the adult ovariectomized female rat.Does IL-6 release ACTH by exerting a direct effect in the rat anterior pituitary.Hypophysiotropic role and hypothalamic gene expression of corticotropin-releasing factor and vasopressin in rats injected with interleukin-1 beta systemically or into the brain ventricles.Influence of carbon monoxide, and its interaction with nitric oxide, on the adrenocorticotropin hormone response of the normal rat to a physico-emotional stress.Distribution and quantification of corticotropin-releasing hormone (CRH) in the brain of the teleost fish Oreochromis mossambicus (tilapia).A role for a helical connector between two receptor binding sites of a long-chain peptide hormone.
P2860
Q24314090-4A609D59-6C43-44DB-80A6-CAB7A39B22D5Q27643440-795AEDDE-3372-49DE-BBF3-C48294FE0F69Q27644056-9302A025-4BE2-40DD-BA27-61484503B73BQ27664491-01DAA6EF-1B1E-45DD-BB93-35CB019B6979Q28572982-28AF71C7-2CB4-473A-BDC1-694F14ECEFF6Q30467138-85DB2F94-842C-428D-BDC3-8A4CCC8E910AQ30502566-E0F824F7-96D7-44AC-9A2D-2D4E74A9EBCAQ33179984-07B8BDE7-4DA7-46AD-9F59-F8062647587CQ34645226-795E7D1F-E408-48C1-AA4B-E02B1E7D968CQ35148867-AD538E0A-6877-42D7-B928-710A766E595BQ35217624-2E14B4EA-29A3-47E2-BBC5-4DDA1CC60EDCQ37034902-4B9CC4E2-0EE7-4291-9704-AC3A27A20567Q37357479-E707C486-719C-49B6-A69D-F12BFDF3AF32Q37454470-B0BC0B2F-5155-455A-BB1A-33D9D4FA8417Q37662647-14772E7D-C6A1-43F7-92B3-F193F831E1C7Q40126897-7C8163C5-A210-4CB9-B3B9-DB2399DE27E3Q41350674-4EB48D96-7DFF-4E8E-9D72-B2E894263F60Q41677831-6401C875-857E-48E5-AFE6-1D37E313D217Q43851708-C5403392-793C-403D-A1D0-368CC67CCFC3Q44066548-4C8E5EC6-0E78-4CD2-A4A1-847902E55A3FQ44410569-FEA701F5-3862-4846-B8D2-8BC8B411B188Q44784411-9CABCB87-5945-41F7-A65D-601F42FC642CQ46028423-0D122AA9-0083-443E-BBCD-54999B8FD75CQ46779708-CE0FAB00-E741-42F0-81EA-CC3A950DFA0DQ47743864-C9A31FBD-77CD-4B62-B1F5-04A758646014Q48147142-E16A6FDE-C700-4EBE-A114-7591699DB27CQ48365106-F2553785-6F5A-45D6-9E81-A4E6E8091778Q48469124-199DB92C-28C6-4739-ACBC-C32FD3F20748Q52974117-D680EB9A-4EB7-46E4-A5BF-862CE6BD124C
P2860
Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Alanine series of ovine cortic ...... e-activity relationship study.
@en
Alanine series of ovine corticotropin releasing factor
@nl
type
label
Alanine series of ovine cortic ...... e-activity relationship study.
@en
Alanine series of ovine corticotropin releasing factor
@nl
prefLabel
Alanine series of ovine cortic ...... e-activity relationship study.
@en
Alanine series of ovine corticotropin releasing factor
@nl
P2093
P356
P1476
Alanine series of ovine cortic ...... e-activity relationship study.
@en
P2093
Donaldson CJ
Hernandez JF
Kornreich WD
Yamamoto G
P304
P356
10.1021/JM00088A024
P407
P577
1992-05-01T00:00:00Z